CIK 0001191070 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Neuphoria Therapeutics Inc.
Sign in to watch- Ticker
- NEUP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- Australia
- Entity type
- operating
- Phone
- 781-439-5551
- Business address
- 100 SUMMIT DR, BURLINGTON, MA, 01803
- Former names
- BIONOMICS LIMITED/FI
- 424B5 Offering Prospectus
- 8-K Event Delisting notice
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4/A Insider Changes in Ownership
- NT 10-Q Other NT 10-Q
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 4 of 21 · 420 filings